0 Comentários
0 Compartilhamentos
251 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Clinical Recognition and Data Sharing: Key Aicardi Syndrome Market trends in Rare Disease Management and DiagnosisThe primary Aicardi Syndrome Market trends are characterized by the increasing technological sophistication of diagnostics and a global movement toward collaborative rare disease management. A key trend is the wider and faster adoption of next-generation sequencing (NGS) technology in pediatric neurology. NGS, particularly whole-exome and whole-genome sequencing, is increasingly becoming...0 Comentários 0 Compartilhamentos 585 Visualizações 0 Anterior
-
Gene Therapy for Rare Disease Market to Grow at a CAGR of 35.5% Through 2032“According to a new report published by Introspective Market Research, Gene Therapy for Rare Disease Market by Therapy Type, Vector Type, and Indication, The Global Gene Therapy for Rare Disease Market Size Was Valued at USD 101.5 Billion in 2023 and is Projected to Reach USD 2,869.54 Billion by 2032, Growing at a CAGR of 35.5% from 2024–2032.” Gene therapy for rare diseases...0 Comentários 0 Compartilhamentos 203 Visualizações 0 Anterior
-
Growing Commercial Demand Fuels the U.S Rare Disease Diagnostics MarketPolaris Market Research has published a new report titled U.S. Rare Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Gastroenterology Disease, Endocrine and Metabolism Disorders Disease, Cardiovascular Disorders, Musculoskeletal Disorders, Neurology Disease, Hematology and Oncology Disease, Dermatology Disease, And Others), By Product Type, By...0 Comentários 0 Compartilhamentos 327 Visualizações 0 Anterior
-
Hereditary Angioedema Therapeutic Market – Rare Disease Innovation, Targeted Biologics & Treatment Accessibility"Executive Summary Hereditary Angioedema Therapeutic Market: Growth Trends and Share Breakdown CAGR Value The global hereditary angioedema therapeutic market size was valued at USD 4.25 billion in 2024 and is expected to reach USD 8.29 billion by 2032, at a CAGR of 8.72% during the forecast period The Hereditary Angioedema Therapeutic Market report has been formed with the appropriate...0 Comentários 0 Compartilhamentos 209 Visualizações 0 Anterior
-
Niemann-Pick Disease Type C Drugs Market – Rare Neurodegenerative Therapies, Orphan Drug Development & Research Funding"Regional Overview of Executive Summary Niemann-pick Disease Type C Drugs Market by Size and Share CAGR Value The global Niemann-pick Disease Type C Drugs market size was valued at USD 708.75 million in 2024 and is projected to reach USD 2024.61 million by 2032, with a CAGR of 14.02% during the forecast period of 2025 to 2032 A consistent market research report like Niemann-pick...0 Comentários 0 Compartilhamentos 221 Visualizações 0 Anterior
-
Organ-on-Chip Market: Disease Modeling Capabilities Advance Rare Condition ResearchA new growth forecast report titled Organ-on-a-Chip Market Size, Share, Trends, Industry Analysis Report By Product & Services (Products, Services), By Application, By End Use, By Region – Market Forecast, 2025–2034 introduced by Polaris Market Research represents conclusive data on the overall market. It majorly targets to provide a detailed analysis of growth factors,...0 Comentários 0 Compartilhamentos 14 Visualizações 0 Anterior
-
Orphan Drug Development Fuels Demand in Rare Disease Genetic Testing MarketPolaris Market Research has announced the latest report, namely Rare Disease Genetic Testing Market Size, Share, Trends, Industry Analysis Report: By Technology, Speciality (Molecular Genetic Tests, Chromosomal Genetic Tests, and Biochemical Genetic Tests), Disease Type, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market...0 Comentários 0 Compartilhamentos 200 Visualizações 0 Anterior
-
Orphan Drug Development Fuels Demand in Rare Disease Genetic Testing MarketPolaris Market Research has announced the latest report, namely Rare Disease Genetic Testing Market Size, Share, Trends, Industry Analysis Report: By Technology, Speciality (Molecular Genetic Tests, Chromosomal Genetic Tests, and Biochemical Genetic Tests), Disease Type, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market...0 Comentários 0 Compartilhamentos 166 Visualizações 0 Anterior
-
Orphan Drugs Market – Rare Disease Commercialization, Incentive-Led Innovation & High-Value Therapeutics"What’s Fueling Executive Summary Orphan Drugs Market Size and Share Growth CAGR Value The global orphan drugs market size was valued at USD 208.76 billion in 2024 and is expected to reach USD 431.48 billion by 2032, at a CAGR of 9.50% during the forecast period To formulate an all-inclusive Orphan Drugs Market report, detailed market analysis has been performed with the inputs...0 Comentários 0 Compartilhamentos 341 Visualizações 0 Anterior
-
Progress in Rare Disease Research: Insights into the Alagille Syndrome Market“According to a new report published by Introspective Market Research, titled, Alagille Syndrome Market by Treatment Type, Distribution Channel, and End-User, The Global Alagille Syndrome Market Size Was Valued at USD 384.06 Billion in 2023 and is Projected to Reach USD 718.05 Billion by 2032, Growing at a CAGR of 7.2%.” Introduction / Market Overview The Alagille...0 Comentários 0 Compartilhamentos 530 Visualizações 0 Anterior
-
Rare Disease Treatment Market Growth and Future Forecast"Executive Summary Rare Disease Treatment Market Value, Size, Share and Projections The global rare disease treatment market size was valued at USD 7.02 billion in 2024 and is projected to reach USD 15.11 billion by 2032, with a CAGR of 10.10% during the forecast period of 2025 to 2032. Being a comprehensive in nature, Rare Disease Treatment Market report undeniably meets the...0 Comentários 0 Compartilhamentos 654 Visualizações 0 Anterior
-
Acquired Methemoglobinemia Market Sees Research Momentum and Drug Innovation Globally Through 2032"Executive Summary Acquired Methemoglobinemia Market : CAGR Value The global acquired methemoglobinemia market size was valued at USD 1.93 billion in 2024 and is projected to reach USD 2.81 billion by 2032, with a CAGR of 4.80% during the forecast period of 2025 to 2032. This global Acquired Methemoglobinemia Market research report is organized by collecting market research data...0 Comentários 0 Compartilhamentos 995 Visualizações 0 Anterior
-
Global Ankylosing Hyperostosis Market Gains Clinical Attention with Better Imaging and Treatment Modalities"Executive Summary Ankylosing Hyperostosis Market : CAGR Value The global ankylosing hyperostosis market size was valued at USD 6.01 billion in 2024 and is projected to reach USD 8.23 billion by 2032, with a CAGR of 4.00% during the forecast period of 2025 to 2032. The Ankylosing Hyperostosis Market report has been designed in such a way that it proves to be the most appropriate...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Idiopathic Pulmonary Fibrosis Market to Hit USD 7.40 Billion by 2032“According to a new report published by Introspective Market Research, Idiopathic Pulmonary Fibrosis Market by Drug Class, Route of Administration, and Distribution Channel, The Global Idiopathic Pulmonary Fibrosis Market Size Was Valued at USD 4.03 Billion in 2023 and is Projected to Reach USD 7.40 Billion by 2032, Growing at a CAGR of 6.99% From 2024–2032.” Idiopathic...0 Comentários 0 Compartilhamentos 3 Visualizações 0 Anterior
Páginas impulsionada
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek